943323-35-1 Usage
General Description
The chemical (2-amino-3-phenyl-propyl)-carbamic acid tert-butyl ester is an organic compound with the chemical formula C13H20N2O2. It is a carbamate compound used in the pharmaceutical industry as a reagent in the synthesis of various drugs and pharmaceutical compounds. The tert-butyl ester group is commonly used to protect the amino group in organic synthesis. (2-AMINO-3-PHENYL-PROPYL)-CARBAMIC ACID TERT-BUTYL ESTER is also used as an intermediate in the production of agricultural chemicals and in the manufacture of dyes and pigments. Additionally, it has potential applications in the field of material science and as a building block for the synthesis of complex organic molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 943323-35-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,3,3,2 and 3 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 943323-35:
(8*9)+(7*4)+(6*3)+(5*3)+(4*2)+(3*3)+(2*3)+(1*5)=161
161 % 10 = 1
So 943323-35-1 is a valid CAS Registry Number.
943323-35-1Relevant articles and documents
A Novel Entry to 3,4,5-Trisubstituted 2-Pyrrolidones from Isoxazoline-N-oxides
Zhmurov, Petr A.,Ushakov, Pavel Yu.,Novikov, Roman A.,Sukhorukov, Alexey Yu.,Ioffe, Sema L.
supporting information, p. 1871 - 1874 (2018/08/28)
A novel strategy for the synthesis of stereochemically defined 3,4,5-trisubstituted 2-pyrrolidones was developed. The suggested approach involves reductive domino-type recyclization of 3-aminomethyl-substituted isoxazolines as a key stage. The latter are prepared via α-C-H functionalization of readily available isoxazoline-N-oxides.
1,2-DIAMIDO-ETHYLENE DERIVATIVES AS OREXIN ANTAGONISTS
-
Page/Page column 28, (2011/11/06)
The invention relates to 1,2-diamido-ethylene derivatives of the formula (I) wherein R1, R2, R3, and A are as described in the description and their use as medicaments, especially as orexin receptor antagonists.
INHIBITORS OF AKT ACTIVITY
-
, (2008/12/08)
-